Oramed Pharmaceuticals, Inc.
(NASDAQ : ORMP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -0.43%55.616.5%$168.43m
CTLTCatalent, Inc. 1.15%78.362.1%$113.54m
VRXValeant Pharmaceuticals International, Inc. -1.67%17.1214.1%$100.74m
JAZZJazz Pharmaceuticals Plc 0.52%106.102.4%$77.04m
UTHRUnited Therapeutics Corp. 0.93%117.0314.3%$68.08m
BHCBausch Health Cos., Inc. -1.72%17.110.0%$64.33m
ICPTIntercept Pharmaceuticals, Inc. -1.44%42.5116.8%$62.06m
PCRXPacira Biosciences, Inc. -1.40%54.8010.3%$54.00m
AXSMAxsome Therapeutics, Inc. 2.39%78.581.9%$49.34m
ZGNXZogenix, Inc. 1.70%26.947.5%$48.05m
MYOKMyoKardia, Inc. 1.53%92.011.8%$43.87m
PRGOPerrigo Co. Plc 0.59%55.866.8%$43.77m
GWPHGW Pharmaceuticals Plc 4.07%137.576.2%$42.91m
ARGXargenx SE 0.26%251.460.0%$42.14m
ICLRICON plc 3.23%177.344.3%$38.53m

Company Profile

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.